The effect of food and liquid pH on the integrity of enteric-coated beads from cysteamine bitartrate delayed-release capsules
Nadine Pavloff,1 Terry A Hauser,1 Chris Williams,2 Sara Louis Isbell,1 Ben Cadieux,1 Mark Johnson1 1Horizon Pharma, Inc., Lake Forest, IL, USA; 2Alcami Corporation, Wilmington, NC, USA Background: Cysteamine bitartrate delayed-release (DR) capsule (Procysbi®) is approved for treat...
Main Authors: | Pavloff N, Hauser TA, Williams C, Isbell SL, Cadieux B, Johnson M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-09-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/the-effect-of-food-and-liquid-ph-on-the-integrity-of-enteric-coated-be-peer-reviewed-article-DDDT |
Similar Items
-
A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis
by: Christina van Stein, et al.
Published: (2021-09-01) -
The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case Series
by: Susmito Biswas, et al.
Published: (2018-12-01) -
A novel sustained‐release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers
by: Cécile L. Berends, et al.
Published: (2021-04-01) -
Ophthalmic Evaluation of Diagnosed Cases of Eye Cystinosis: A Tertiary Care Center’s Experience
by: Malgorzata Kowalczyk, et al.
Published: (2020-11-01) -
Worldwide view of nephropathic cystinosis: results from a survey from 30 countries
by: Aurélia Bertholet-Thomas, et al.
Published: (2017-07-01)